The global sensory organ drugs market size is expected to reach USD 42.01 Billion in 2032 and register a steady revenue CAGR of 5.3% during the forecast period, according to the latest analysis by Emergen Research. Rising prevalence of eye and ear infections as well as nasal infections across the globe, government initiatives and increasing collaborations for development of pharmaceutical drugs in the healthcare sector, and an increasing number of clinical trials for development of sensory organ pharmaceutical drugs are crucial factors driving revenue growth of this market. To receive a PDF sample of the report, visit @ https://www.emergenresearch.com/request-sample/1641